{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:47:43Z","timestamp":1791312463397,"version":"4.3.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"am","delay-in-days":468,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00AG040149"],"award-info":[{"award-number":["R00AG040149"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1653866"],"award-info":[{"award-number":["1653866"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["F1785"],"award-info":[{"award-number":["F1785"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biomedical Engineering"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cobme.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T14:46:21Z","timestamp":1490193981000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Immune engineering: From systems immunology to engineering immunity"],"prefix":"10.1016","volume":"1","author":[{"given":"Ning","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cobme.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/2281045a0","article-title":"Variability in the lambda light chain sequences of mouse antibody","volume":"228","author":"Weigert","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.1987.tb00507.x","article-title":"Mutation drift and repertoire shift in the maturation of the immune response","volume":"96","author":"Berek","year":"1987","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cobme.2017.03.002_bib3","first-page":"1","article-title":"A\u00a0study of avidity based on rabbit skin responses to diphtheria toxin-antitoxin mixtures","volume":"87","author":"Jerne","year":"1951","journal-title":"Acta Pathol. Microbiol. Scand. Suppl."},{"key":"10.1016\/j.cobme.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1021\/bi00895a027","article-title":"Variations in affinities of antibodies during the immune response","volume":"3","author":"Eisen","year":"1964","journal-title":"Biochemistry"},{"key":"10.1016\/j.cobme.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1073\/pnas.81.10.3180","article-title":"Generation of antibody diversity in the immune response of BALB\/c mice to influenza virus hemagglutinin","volume":"81","author":"McKean","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1170020","article-title":"High-throughput sequencing of the zebrafish antibody repertoire","volume":"324","author":"Weinstein","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nbt.2782","article-title":"The promise and challenge of high-throughput sequencing of the antibody repertoire","volume":"32","author":"Georgiou","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1101\/gr.092924.109","article-title":"Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing","volume":"19","author":"Freeman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.cobme.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cobme.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"171ra119","DOI":"10.1126\/scitranslmed.3004794","article-title":"Lineage structure of the human antibody repertoire in response to influenza vaccination","volume":"5","author":"Jiang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1073\/pnas.1312146110","article-title":"Genetic measurement of memory B-cell recall using antibody repertoire sequencing","volume":"110","author":"Vollmers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ni.3533","article-title":"Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination","volume":"17","author":"Ellebedy","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ni.3175","article-title":"Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus","volume":"16","author":"Tipton","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"12ra23","DOI":"10.1126\/scitranslmed.3000540","article-title":"Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing","volume":"1","author":"Boyd","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1073\/pnas.1014277108","article-title":"Determinism and stochasticity during maturation of the zebrafish antibody repertoire","volume":"108","author":"Jiang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved Near-Pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cobme.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.aah3945","article-title":"Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice","volume":"353","author":"Sok","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.cell.2016.07.030","article-title":"Sequential immunization elicits broadly neutralizing anti-HIV-1 antibodies in Ig knockin mice","volume":"166","author":"Escolano","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cell.2016.08.005","article-title":"Tailored immunogens direct affinity maturation toward HIV neutralizing antibodies","volume":"166","author":"Briney","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cell.2016.07.029","article-title":"Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires","volume":"166","author":"Tian","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cobme.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.1502563","article-title":"Highly accurate sequencing of full-length immune repertoire amplicons using Tn5-enabled and molecular identifier-guided amplicon assembly","volume":"196","author":"Cole","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib23","article-title":"Lineage tracing of human B cells reveals the in\u00a0vivo landscape of human antibody class switching","volume":"5","author":"Horns","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.cobme.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nbt.2492","article-title":"High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire","volume":"31","author":"Dekosky","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1073\/pnas.1213737110","article-title":"Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response","volume":"110","author":"Wine","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nbt.2938","article-title":"Linking T-cell receptor sequence to functional phenotype at the single-cell level","volume":"32","author":"Han","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib29","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1172\/JCI58653","article-title":"A\u00a0high-throughput single-cell analysis of human CD8(+) T cell functions reveals discordance for cytokine secretion and cytolysis","volume":"121","author":"Varadarajan","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cobme.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2016.01.010","article-title":"In\u00a0vivo killing capacity of cytotoxic T cells is limited and involves dynamic Interactions and T Cell cooperativity","volume":"44","author":"Halle","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cobme.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cobme.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cobme.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.2014.58.9093","article-title":"Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells","volume":"33","author":"Stevanovic","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.cobme.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","article-title":"A\u00a0pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response","volume":"21","author":"Robbins","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cobme.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-immunol-020711-075035","article-title":"Selection of self-reactive T cells in the thymus","volume":"30","author":"Stritesky","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cobme.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"341ra377","DOI":"10.1126\/scitranslmed.aaf1278","article-title":"Direct measurement of T cell receptor affinity and sequence from naive antiviral T cells","volume":"8","author":"Zhang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1073\/pnas.0500090102","article-title":"The response of autologous T cells to a human melanoma is dominated by mutated neoantigens","volume":"102","author":"Lennerz","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature13387","article-title":"A\u00a0vaccine targeting mutant IDH1 induces antitumour immunity","volume":"512","author":"Schumacher","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature14426","article-title":"Mutant MHC class II epitopes drive therapeutic immune responses to cancer","volume":"520","author":"Kreiter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aad1253","article-title":"Immunogenicity of somatic mutations in human gastrointestinal cancers","volume":"350","author":"Tran","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib46","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature18945","article-title":"Neoantigen landscape dynamics during human melanoma-T cell interactions","volume":"536","author":"Verdegaal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0092-8674(90)90341-B","article-title":"Chimeric immunoglobulin-T cell receptor proteins form functional receptors: implications for T cell receptor complex formation and activation","volume":"60","author":"Goverman","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-med-060512-150254","article-title":"Chimeric antigen receptor therapy for cancer","volume":"65","author":"Barrett","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12243","article-title":"Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies","volume":"263","author":"Gill","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cobme.2017.03.002_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nm.4015","article-title":"Prospects for gene-engineered T cell immunotherapy for solid cancers","volume":"22","author":"Klebanoff","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-1759(00)00343-4","article-title":"Functional expression of chimeric receptor genes in human T cells","volume":"248","author":"Eshhar","year":"2001","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cobme.2017.03.002_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib55","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2011-10-387969","article-title":"CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results","volume":"119","author":"Till","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cobme.2017.03.002_bib56","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.276.5319.1719","article-title":"HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia","volume":"276","author":"Bonini","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nm0296-216","article-title":"T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients","volume":"2","author":"Riddell","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib58","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9\u00a0safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cobme.2017.03.002_bib59","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A\u00a0transgene-encoded cell surface polypeptide for selection, in\u00a0vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cobme.2017.03.002_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nbt.2459","article-title":"Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells","volume":"31","author":"Kloss","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib61","doi-asserted-by":"crossref","first-page":"215ra172","DOI":"10.1126\/scitranslmed.3006597","article-title":"PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses","volume":"5","author":"Fedorov","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib62","doi-asserted-by":"crossref","first-page":"aab4077","DOI":"10.1126\/science.aab4077","article-title":"Remote control of therapeutic T cells through a small molecule-gated chimeric receptor","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib63","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.immuni.2016.05.014","article-title":"Engineered CAR T cells targeting the cancer-associated Tn-glycoform of the membrane mucin MUC1 control adenocarcinoma","volume":"44","author":"Posey","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cobme.2017.03.002_bib64","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/mt.2013.17","article-title":"Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity","volume":"21","author":"Lamers","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cobme.2017.03.002_bib65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib66","series-title":"Fitzpatrick's Dermatology in General Medicine","author":"Goldsmith","year":"2012"},{"key":"10.1016\/j.cobme.2017.03.002_bib67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/328267a0","article-title":"A\u00a0new member of the immunoglobulin superfamily\u2013CTLA-4","volume":"328","author":"Brunet","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.cobme.2017.03.002_bib68","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation","volume":"173","author":"Linsley","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib70","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cobme.2017.03.002_bib71","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib72","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib73","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20100619","article-title":"VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses","volume":"208","author":"Wang","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib74","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20130590","article-title":"Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy","volume":"211","author":"Fan","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib75","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1158\/0008-5472.CAN-12-4174","article-title":"OX40 is a potent immune-stimulating target in late-stage cancer patients","volume":"73","author":"Curti","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cobme.2017.03.002_bib76","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib78","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib79","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib80","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib82","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib83","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","article-title":"Generation of knock-in primary human T cells using Cas9 ribonucleoproteins","volume":"112","author":"Schumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cobme.2017.03.002_bib84","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.cobme.2017.03.002_bib85","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cobme.2017.03.002_bib86","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/nbt.3711","article-title":"Revealing the vectors of cellular identity with single-cell genomics","volume":"34","author":"Wagner","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1126\/science.aaf5453","article-title":"Writ large: genomic dissection of the effect of cellular environment on immune response","volume":"354","author":"Yosef","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib88","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nbt.2783","article-title":"Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells","volume":"32","author":"Newell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cobme.2017.03.002_bib90","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cobme.2017.03.002_bib91","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nm.4200","article-title":"Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses","volume":"22","author":"Moynihan","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cobme.2017.03.002_bib92","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T cells with customized therapeutic response programs using synthetic notch receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cobme.2017.03.002_bib93","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1016\/j.biomaterials.2009.05.024","article-title":"Engineering liver tissue spheroids with inverted colloidal crystal scaffolds","volume":"30","author":"Lee","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.cobme.2017.03.002_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40824-016-0067-1","article-title":"Engineering approaches for regeneration of T lymphopoiesis","volume":"20","author":"Roh","year":"2016","journal-title":"Biomater. Res."},{"key":"10.1016\/j.cobme.2017.03.002_bib95","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/mt.2015.77","article-title":"Bioengineering thymus organoids to restore thymic function and induce donor-specific immune tolerance to allografts","volume":"23","author":"Fan","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cobme.2017.03.002_bib96","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biomaterials.2015.06.002","article-title":"Ex\u00a0vivo engineered immune organoids for controlled germinal center reactions","volume":"63","author":"Purwada","year":"2015","journal-title":"Biomaterials"}],"container-title":["Current Opinion in Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468451116300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468451116300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:57:28Z","timestamp":1762844248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468451116300083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":96,"alternative-id":["S2468451116300083"],"URL":"https:\/\/doi.org\/10.1016\/j.cobme.2017.03.002","relation":{},"ISSN":["2468-4511"],"issn-type":[{"value":"2468-4511","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune engineering: From systems immunology to engineering immunity","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biomedical Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cobme.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}